Last reviewed · How we verify
Primary Prevention of Coronary Heart Disease
Approved treatments
- Lipitor · Pfizer Inc.
Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis. - Lopid · Pfizer
- Crestor · AstraZeneca
Rosuvastatin inhibits HMG-CoA reductase, the rate-limiting enzyme converting HMG-CoA to mevalonate, a cholesterol precursor. - Lipitor · Pfizer
Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis. - Norvasc · Pfizer Inc.
Long-acting dihydropyridine calcium channel blocker that relaxes vascular smooth muscle, reducing blood pressure and myocardial oxygen demand. - Mevacor · Merck & Co.
Mevacor works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver. - Amlodipin · Boehringer Ingelheim
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Primary Prevention of Coronary Heart Disease patent landscape — cliff calendar, originator estates, attackable patents
- Primary Prevention of Coronary Heart Disease treatment landscape brief
- Primary Prevention of Coronary Heart Disease treatment updates RSS
Frequently asked questions about Primary Prevention of Coronary Heart Disease
What drugs treat Primary Prevention of Coronary Heart Disease?
Tracked treatments include Lipitor, Lopid, Crestor, Norvasc, Mevacor, Amlodipin.
What is the treatment for Primary Prevention of Coronary Heart Disease?
Standard treatment for Primary Prevention of Coronary Heart Disease includes Lipitor, Lopid, Crestor, Norvasc, Mevacor. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Primary Prevention of Coronary Heart Disease patent cliff · Primary Prevention of Coronary Heart Disease CI report
- Treatment: Lipitor · Pfizer Inc.
- Treatment: Lopid · Pfizer
- Treatment: Crestor · AstraZeneca
- Treatment: Lipitor · Pfizer
- Treatment: Norvasc · Pfizer Inc.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing